Why is the U.S. at risk of losing its measles elimination status? And what did top CMS official Mehmet Oz tell hospital ...

Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to ...

Lexicon Pharmaceuticals, Inc. is downgraded to Hold due to repeated FDA rejections of ZYNQUISTA for T1D and catalysts. Read more on LXRX stock here.

Endometriosis is a prevalent yet underdiagnosed disease affecting a large population of women of reproductive age, with a substantial and lasting impact on quality of life and fertility. While rising ...

This deal marks another addition to BMS’s growing pipeline, which the company hopes will stave off the impacts of the ...

Backed with $82 million and led by two of BioMarin’s former executives, Mendra plans to acquire rare disease assets and use ...

Ellipses Pharma Limited (“Ellipses”), a clinical-stage oncology drug development company with a pipeline of innovative ...

Fueled by advances in biomarkers, brain mapping, and AI, investment in neuro and CNS innovation shows no signs of slowing, even amid costly setbacks. BioSpace spoke to investors at JPM26 to get their ...

Economist David C. Datelle says the pharmaceutical industry's prices have less to do with innovation than with corporate ...

GSK acquires Rapt Therapeutics for $2.2B. Stock surges 65% as pharma giant gains access to phase 2b food allergy treatment ...

Stability is a critical factor in drug formulation, with implications for product quality, lifecycle management, and ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...